1. Home
  2. FRES vs NURO Comparison

FRES vs NURO Comparison

Compare FRES & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRES
  • NURO
  • Stock Information
  • Founded
  • FRES 2010
  • NURO 1996
  • Country
  • FRES United States
  • NURO United States
  • Employees
  • FRES N/A
  • NURO N/A
  • Industry
  • FRES Medical Specialities
  • NURO Medical/Dental Instruments
  • Sector
  • FRES Health Care
  • NURO Health Care
  • Exchange
  • FRES Nasdaq
  • NURO Nasdaq
  • Market Cap
  • FRES 6.4M
  • NURO 7.7M
  • IPO Year
  • FRES 2020
  • NURO N/A
  • Fundamental
  • Price
  • FRES $2.65
  • NURO $3.69
  • Analyst Decision
  • FRES
  • NURO
  • Analyst Count
  • FRES 0
  • NURO 0
  • Target Price
  • FRES N/A
  • NURO N/A
  • AVG Volume (30 Days)
  • FRES 10.6K
  • NURO 8.3K
  • Earning Date
  • FRES 09-17-2024
  • NURO 07-29-2024
  • Dividend Yield
  • FRES N/A
  • NURO N/A
  • EPS Growth
  • FRES N/A
  • NURO N/A
  • EPS
  • FRES N/A
  • NURO N/A
  • Revenue
  • FRES $2,345,304.00
  • NURO $5,270,210.00
  • Revenue This Year
  • FRES N/A
  • NURO N/A
  • Revenue Next Year
  • FRES N/A
  • NURO N/A
  • P/E Ratio
  • FRES N/A
  • NURO N/A
  • Revenue Growth
  • FRES N/A
  • NURO N/A
  • 52 Week Low
  • FRES $2.50
  • NURO $2.70
  • 52 Week High
  • FRES $41.50
  • NURO $7.92
  • Technical
  • Relative Strength Index (RSI)
  • FRES 36.56
  • NURO 46.28
  • Support Level
  • FRES $2.56
  • NURO $3.50
  • Resistance Level
  • FRES $3.40
  • NURO $4.10
  • Average True Range (ATR)
  • FRES 0.35
  • NURO 0.15
  • MACD
  • FRES -0.03
  • NURO 0.01
  • Stochastic Oscillator
  • FRES 12.50
  • NURO 31.57

About FRES Fresh2 Group Limited

Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

Share on Social Networks: